Varlilumab: A Deep Dive into CDX-1127 and its Mechanism The antibody (formerly known as PRT-052) represents a novel therapeutic molecule targeting this surface receptor. This drug's function depends on binding to this https://www.targetmol.com/compound/varlilumab